VNDA Stephen Ray Mitchell sells $32K worth of shares
Jun 17, 2025, 4:34 AM
0.00%
What does VNDA do
Vanda Pharmaceuticals, headquartered in Washington, D.C., develops therapies for unmet medical needs and has three commercial products, including HETLIOZ and Fanapt. The company also has multiple drugs in development.
Stephen Ray Mitchell sold 7,000 shares of VNDA on 13 June at $4.59 per share, worth a total of $32K. They now own 97,082 VNDA shares, or a 7% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
